Skip to main content
Top
Published in: Inflammation 4/2011

01-08-2011

C-Reactive Protein Induces TNF-α Secretion by p38 MAPK–TLR4 Signal Pathway in Rat Vascular Smooth Muscle Cells

Authors: Na Liu, Juntian Liu, Yuanyuan Ji, Peipei Lu, Chenjing Wang, Fang Guo

Published in: Inflammation | Issue 4/2011

Login to get access

Abstract

Atherosclerosis is a chronic inflammatory disease. C-reactive protein (CRP) not only is an inflammatory marker but also regulates the expressions of other inflammatory cytokines associated with the pathogenesis of atherosclerosis. Toll-like receptor 4 (TLR4) also contributes to atherogenesis via transducting inflammatory signals. Herein, our studies focused on characterizing the effect of CRP on tumor necrosis factor α (TNF-α) production and TLR4-related molecular mechanisms in rat vascular smooth muscle cells (VSMCs). The results showed that CRP stimulated VSMCs to secrete TNF-α and enhanced TLR4 expression in a time-concentration-dependent manner. TLR4 knockdown significantly inhibited CRP-induced TNF-α generation, and p38 mitogen-activated protein kinase (MAPK) blocker SB203580 depressed TLR4 expression and TNF-α production initiated by CRP in VSMCs. The data demonstrate that CRP triggers an inflammatory response in rat VSMCs by inducing TNF-α secretion, which is mediated by p38 MAPK–TLR4 signaling pathway.
Literature
1.
go back to reference Hansson, G.K. 2005. Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 352: 1685–1695.PubMedCrossRef Hansson, G.K. 2005. Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 352: 1685–1695.PubMedCrossRef
2.
3.
go back to reference Ng, S.B., Y.H. Tan, and G.R. Guy. 1994. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. The Journal of Biological Chemistry 269: 19021–19027.PubMed Ng, S.B., Y.H. Tan, and G.R. Guy. 1994. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. The Journal of Biological Chemistry 269: 19021–19027.PubMed
4.
go back to reference Jovinge, S., A. Hamsten, P. Tornvall, A. Proudler, P. Båvenholm, C. Ericsson, I. Godsland, U. de Faire, and J. Nilsson. 1998. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 47: 113–118.PubMedCrossRef Jovinge, S., A. Hamsten, P. Tornvall, A. Proudler, P. Båvenholm, C. Ericsson, I. Godsland, U. de Faire, and J. Nilsson. 1998. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 47: 113–118.PubMedCrossRef
5.
go back to reference Blake, G.J., and P.M. Ridker. 2001. Novel clinical markers of vascular wall inflammation. Circulation Research 89: 763–771.PubMedCrossRef Blake, G.J., and P.M. Ridker. 2001. Novel clinical markers of vascular wall inflammation. Circulation Research 89: 763–771.PubMedCrossRef
6.
go back to reference Pasceri, V., J.T. Willerson, and E.T.H. Yeh. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165–2168.PubMed Pasceri, V., J.T. Willerson, and E.T.H. Yeh. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165–2168.PubMed
7.
go back to reference Hattori, Y., M. Matsumura, and K. Kasai. 2003. Vascular smooth muscle cell activation by C-reactive protein. Cardiovascular Research 58: 186–195.PubMedCrossRef Hattori, Y., M. Matsumura, and K. Kasai. 2003. Vascular smooth muscle cell activation by C-reactive protein. Cardiovascular Research 58: 186–195.PubMedCrossRef
9.
go back to reference Edfeldt, K., J. Swedenborg, G.K. Hansson, and Z. Yan. 2002. Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation 105: 1158–1161.PubMed Edfeldt, K., J. Swedenborg, G.K. Hansson, and Z. Yan. 2002. Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation 105: 1158–1161.PubMed
10.
go back to reference Michelsen, K.S., T.M. Doherty, P.K. Shah, and M. Arditi. 2004. TLR signaling: An emerging bridge from innate immunity to atherogenesis. Journal of Immunology 173: 5901–5907. Michelsen, K.S., T.M. Doherty, P.K. Shah, and M. Arditi. 2004. TLR signaling: An emerging bridge from innate immunity to atherogenesis. Journal of Immunology 173: 5901–5907.
11.
go back to reference Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signaling. Nature 430: 257–263.PubMedCrossRef Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signaling. Nature 430: 257–263.PubMedCrossRef
12.
go back to reference Tobias, P., and L.K. Curtiss. 2005. Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: Toll receptors in atherogenesis. Journal of Lipid Research 46: 404–411.PubMedCrossRef Tobias, P., and L.K. Curtiss. 2005. Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: Toll receptors in atherogenesis. Journal of Lipid Research 46: 404–411.PubMedCrossRef
13.
go back to reference Faure, E., O. Equils, P.A. Sieling, L. Thomas, F.X. Zhang, C.J. Kirschning, N. Polentaruttii, M. Muzioi, and M. Arditi. 2000. Bacterial lipopolysaccharide activates NF-κB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells: Differential expression of TLR-4 and TLR-2 in endothelial cells. The Journal of Biological Chemistry 275: 11058–11063.PubMedCrossRef Faure, E., O. Equils, P.A. Sieling, L. Thomas, F.X. Zhang, C.J. Kirschning, N. Polentaruttii, M. Muzioi, and M. Arditi. 2000. Bacterial lipopolysaccharide activates NF-κB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells: Differential expression of TLR-4 and TLR-2 in endothelial cells. The Journal of Biological Chemistry 275: 11058–11063.PubMedCrossRef
14.
go back to reference An, H., Y. Yu, M. Zhang, H. Xu, R. Qi, X. Yan, S. Liu, W. Wang, Z. Guo, J. Guo, Z. Qin, and X. Cao. 2002. Involvement of ERK, p38 and NF-κB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 106: 38–45.PubMedCrossRef An, H., Y. Yu, M. Zhang, H. Xu, R. Qi, X. Yan, S. Liu, W. Wang, Z. Guo, J. Guo, Z. Qin, and X. Cao. 2002. Involvement of ERK, p38 and NF-κB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 106: 38–45.PubMedCrossRef
15.
go back to reference Yang, X., D. Coriolan, V. Murthy, K. Schultz, D.T. Golenbock, and D. Beasley. 2005. Proinflammatory phenotype of vascular smooth muscle cells: Role of efficient Toll-like receptor 4 signaling. American Journal of Physiology. Heart and Circulatory Physiology 89: H1069–H1076.CrossRef Yang, X., D. Coriolan, V. Murthy, K. Schultz, D.T. Golenbock, and D. Beasley. 2005. Proinflammatory phenotype of vascular smooth muscle cells: Role of efficient Toll-like receptor 4 signaling. American Journal of Physiology. Heart and Circulatory Physiology 89: H1069–H1076.CrossRef
16.
go back to reference Frantz, S., G. Ertl, and J. Bauersachs. 2007. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nature Clinical Practice. Cardiovascular Medicine 4: 444–454.PubMedCrossRef Frantz, S., G. Ertl, and J. Bauersachs. 2007. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nature Clinical Practice. Cardiovascular Medicine 4: 444–454.PubMedCrossRef
17.
go back to reference Heo, S.K., H.J. Yun, E.K. Noh, W.H. Park, and S.D. Park. 2008. LPS induces inflammatory responses in human aortic vascular smooth muscle cells via toll-like receptor 4 expression and nitric oxide production. Immunology Letters 120: 57–64.PubMedCrossRef Heo, S.K., H.J. Yun, E.K. Noh, W.H. Park, and S.D. Park. 2008. LPS induces inflammatory responses in human aortic vascular smooth muscle cells via toll-like receptor 4 expression and nitric oxide production. Immunology Letters 120: 57–64.PubMedCrossRef
18.
go back to reference Ji, Y.Y., J.T. Liu, Z.D. Wang, and N. Liu. 2009. Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cellular Physiology and Biochemistry 23: 265–276.PubMedCrossRef Ji, Y.Y., J.T. Liu, Z.D. Wang, and N. Liu. 2009. Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cellular Physiology and Biochemistry 23: 265–276.PubMedCrossRef
19.
go back to reference Ong, K.G., J.M. Leland, K. Zeng, G. Barrett, M. Zourob, and C.A. Grimes. 2006. A rapid highly-sensitive endotoxin detection system. Biosensors & Bioelectronics 21: 2270–2274.CrossRef Ong, K.G., J.M. Leland, K. Zeng, G. Barrett, M. Zourob, and C.A. Grimes. 2006. A rapid highly-sensitive endotoxin detection system. Biosensors & Bioelectronics 21: 2270–2274.CrossRef
20.
go back to reference Pearson, T.A., G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon 3rd, M. Criqui, Y.Y. Fadl, S.P. Fortmann, Y. Hong, G.L. Myers, N. Rifai, S.C. Smith Jr., K. Taubert, R.P. Tracy, and F. Vinicor. 2003. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499–511.PubMedCrossRef Pearson, T.A., G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon 3rd, M. Criqui, Y.Y. Fadl, S.P. Fortmann, Y. Hong, G.L. Myers, N. Rifai, S.C. Smith Jr., K. Taubert, R.P. Tracy, and F. Vinicor. 2003. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499–511.PubMedCrossRef
21.
go back to reference Liuzzo, G., M. Santamaria, L.M. Biasucci, M. Narducci, V. Colafrancesco, A. Porto, S. Brugaletta, M. Pinnelli, V. Rizzello, A. Maseri, and F. Crea. 2007. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein: Evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. Journal of the American College of Cardiology 49: 185–194.PubMedCrossRef Liuzzo, G., M. Santamaria, L.M. Biasucci, M. Narducci, V. Colafrancesco, A. Porto, S. Brugaletta, M. Pinnelli, V. Rizzello, A. Maseri, and F. Crea. 2007. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein: Evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. Journal of the American College of Cardiology 49: 185–194.PubMedCrossRef
22.
go back to reference Marnell, L., C. Mold, and T.W. Du Clos. 2005. C-reactive protein: Ligands, receptors and role in inflammation. Clinical Immunology 117: 104–111.PubMedCrossRef Marnell, L., C. Mold, and T.W. Du Clos. 2005. C-reactive protein: Ligands, receptors and role in inflammation. Clinical Immunology 117: 104–111.PubMedCrossRef
23.
go back to reference Torzewski, M., C. Rist, R.F. Mortensen, T.P. Zwaka, M. Bienek, J. Waltenberger, W. Koenig, G. Schmitz, V. Hombach, and J. Torzewski. 2000. C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 20: 2094–2099.PubMed Torzewski, M., C. Rist, R.F. Mortensen, T.P. Zwaka, M. Bienek, J. Waltenberger, W. Koenig, G. Schmitz, V. Hombach, and J. Torzewski. 2000. C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 20: 2094–2099.PubMed
24.
go back to reference Warner, S.J., and P. Libby. 1989. Human vascular smooth muscle cells: Target for and source of tumor necrosis factor. Journal of Immunology 142: 100–109. Warner, S.J., and P. Libby. 1989. Human vascular smooth muscle cells: Target for and source of tumor necrosis factor. Journal of Immunology 142: 100–109.
25.
go back to reference Barath, P., M.C. Fishbein, J. Cao, J. Berenson, R.H. Helfant, and J.S. Forrester. 1990. Detection and localization of tumor necrosis factor in human atheroma. The American Journal of Cardiology 65: 297–302.PubMedCrossRef Barath, P., M.C. Fishbein, J. Cao, J. Berenson, R.H. Helfant, and J.S. Forrester. 1990. Detection and localization of tumor necrosis factor in human atheroma. The American Journal of Cardiology 65: 297–302.PubMedCrossRef
26.
go back to reference Gao, X., X. Xu, S. Belmadani, Y. Park, Z. Tang, A.M. Feldman, W.M. Chilian, and C. Zhang. 2007. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 1269–1275.PubMedCrossRef Gao, X., X. Xu, S. Belmadani, Y. Park, Z. Tang, A.M. Feldman, W.M. Chilian, and C. Zhang. 2007. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 1269–1275.PubMedCrossRef
28.
go back to reference Michelsen, K.S., M.H. Wong, P.K. Shah, W. Zhang, J. Yano, T.M. Doherty, S. Akira, T.B. Rajavashisth, and M. Arditi. 2004. Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proceedings of the National Academy of Sciences of the United States of America 101: 10679–10684.PubMedCrossRef Michelsen, K.S., M.H. Wong, P.K. Shah, W. Zhang, J. Yano, T.M. Doherty, S. Akira, T.B. Rajavashisth, and M. Arditi. 2004. Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proceedings of the National Academy of Sciences of the United States of America 101: 10679–10684.PubMedCrossRef
29.
go back to reference Lee, Y.B., J.W. Schrader, and S.U. Kim. 2000. p38 MAP kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. Cytokine 12: 874–880.PubMedCrossRef Lee, Y.B., J.W. Schrader, and S.U. Kim. 2000. p38 MAP kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. Cytokine 12: 874–880.PubMedCrossRef
30.
go back to reference Barton, G.M., and R. Medzhitov. 2003. Toll-like receptor signaling pathways. Science 300: 1524–1525.PubMedCrossRef Barton, G.M., and R. Medzhitov. 2003. Toll-like receptor signaling pathways. Science 300: 1524–1525.PubMedCrossRef
31.
go back to reference Lin, F.Y., Y.H. Chen, J.S. Tasi, J.W. Chen, T.L. Yang, H.J. Wang, C.Y. Li, Y.L. Chen, and S.J. Lin. 2006. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arteriosclerosis, Thrombosis, and Vascular Biology 26: 2630–2637.PubMedCrossRef Lin, F.Y., Y.H. Chen, J.S. Tasi, J.W. Chen, T.L. Yang, H.J. Wang, C.Y. Li, Y.L. Chen, and S.J. Lin. 2006. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arteriosclerosis, Thrombosis, and Vascular Biology 26: 2630–2637.PubMedCrossRef
32.
go back to reference Sasu, S., D. LaVerda, N. Qureshi, D.T. Golenbock, and D. Beasley. 2001. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circulation Research 89: 244–250.PubMedCrossRef Sasu, S., D. LaVerda, N. Qureshi, D.T. Golenbock, and D. Beasley. 2001. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circulation Research 89: 244–250.PubMedCrossRef
33.
go back to reference Zaru, R., N. Ronkina, M. Gaestel, J.S.C. Arthur, and C. Watts. 2007. The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nature Immunology 8: 1227–1235.PubMedCrossRef Zaru, R., N. Ronkina, M. Gaestel, J.S.C. Arthur, and C. Watts. 2007. The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nature Immunology 8: 1227–1235.PubMedCrossRef
Metadata
Title
C-Reactive Protein Induces TNF-α Secretion by p38 MAPK–TLR4 Signal Pathway in Rat Vascular Smooth Muscle Cells
Authors
Na Liu
Juntian Liu
Yuanyuan Ji
Peipei Lu
Chenjing Wang
Fang Guo
Publication date
01-08-2011
Publisher
Springer US
Published in
Inflammation / Issue 4/2011
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-010-9234-z

Other articles of this Issue 4/2011

Inflammation 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.